|
1
|
Pacini F: How far should we go in the
search and treatment of recurrent or persistent lymph node
metastases during follow-up of thyroid cancer patients? Eur Thyroid
J. 2:145–146. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brehar AC, Brehar FM, Bulgar AC and
Dumitrache C: Genetic and epigenetic alterations in differentiated
thyroid carcinoma. J Med Life. 6:403–408. 2013.PubMed/NCBI
|
|
4
|
Zou Y, Lu Y and Wei D: Antioxidant
activity of a flavonoid-rich extract of Hypericum perforatum L. in
vitro. J Agric Food Chem. 52:5032–5039. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Song BW, Ma CG and Xu SY: Hyperin: A new
peripheral analgesic agent. Asia Pac J Pharm. 3:1–5. 1998.
|
|
6
|
Waligórska-Stachura J, Jankowska A, Waśko
R, Liebert W, Biczysko M, Czarnywojtek A, Baszko-Błaszyk D, Shimek
V and Ruchała M: Survivin - prognostic tumor biomarker in human
neoplasms - review. Ginekol Pol. 83:537–540. 2012.PubMed/NCBI
|
|
7
|
Myong NH: Tissue microarray analysis of
Fas and FasL expressions in human non-small cell lung carcinomas;
with reference to the p53 and bcl-2 overexpressions. J Korean Med
Sci. 20:770–776. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chang JS, Hsu YL, Kuo PL, Chiang LC and
Lin CC: Upregulation of Fas/Fas ligand-mediated apoptosis by
gossypol in an immortalized human alveolar lung cancer cell line.
Clin Exp Pharmacol Physiol. 31:716–722. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ryan AE, Shanahan F, Oconnell J and
Houston AM: Fas ligand promotes tumor immune evasion of colon
cancer in vivo. Cell Cycle. 5:246–249. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Korkolopoulou P, Saetta AA, Levidou G,
Gigelou F, Lazaris A, Thymara I, Scliri M, Bousboukea K,
Michalopoulos NV, Apostolikas N, et al: c-FLIP expression in
colorectal carcinomas: Association with Fas/FasL expression and
prognostic implications. Histopathology. 51:150–156. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Siegel RM, Chan FK, Chun HJ and Lenardo
MJ: The multifaceted role of Fas signaling in immune cell
homeostasis and autoimmunity. Nat Immunol. 1:469–474. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Morimoto Y, Hizuta A, Ding EX, Ishii T,
Hongo T, Fujiwara T, Iwagaki H and Tanaka N: Functional expression
of Fas and Fas ligand on human intestinal intraepithelial
lymphocytes. Clin Exp Immunol. 116:84–89. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shariat SF, Ashfaq R, Karakiewicz PI,
Saeedi O, Sagalowsky AI and Lotan Y: Survivin expression is
associated with bladder cancer presence, stage, progression, and
mortality. Cancer. 109:1106–1113. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Beardmore VA, Ahonen LJ, Gorbsky GJ and
Kallio MJ: Survivin dynamics increases at centromeres during G2/M
phase transition and is regulated by microtubule-attachment and
Aurora B kinase activity. J Cell Sci. 117:4033–4042. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shimada T, Nishimura Y, Nishiuma T,
Rikitake Y, Hirase T and Yokoyama M: Adenoviral transfer of rho
family proteins to lung cancer cells ameliorates cell proliferation
and motility and increases apoptotic change. Kobe J Med Sci.
53:125–134. 2007.PubMed/NCBI
|
|
16
|
Olie RA, Simões-Wüst AP, Baumann B, Leech
SH, Fabbro D, Stahel RA and Zangemeister-Wittke U: A novel
antisense oligonucleotide targeting survivin expression induces
apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer
Res. 60:2805–2809. 2000.PubMed/NCBI
|
|
17
|
Wu YF, Cao MF, Gao YP, Chen F, Wang T,
Zumbika EP and Qian KX: Down-modulation of heat shock protein 70
and up-modulation of Caspase-3 during schisandrin B-induced
apoptosis in human hepatoma SMMC-7721 cells. World J Gastroenterol.
10:2944–2948. 2004. View Article : Google Scholar : PubMed/NCBI
|
